Melissa Vetter

799 citations
8 papers · 597 indexed · h-index 5
Topics
Chromosomal and Genetic Variations (3 papers)RNA and protein synthesis mechanisms (3 papers)Breast Cancer Treatment Studies (2 papers)

In The Last Decade

Melissa Vetter

7 papers receiving 590 citations

Peers

Melissa Vetter
Comparison fields: 5 of 50
  • Molecular Biology 518
  • Plant Science 429
  • Genetics 109
  • Cancer Research 36
  • Immunology 28
Replace Mart Speek with:
Mart Speek Estonia
Lindsay M. Payer United States
Jared P. Steranka United States
John V. Moran United States
Ramakrishna K. Chodavarapu United States
Alexandre Coudray Switzerland
Brook Pyhtila United States
Sara R. Heras Spain
Kensaku Murano Japan
So Maezawa Japan
Melissa Vetter relative to Mart Speek Estonia Mart Speek's profile →
Citations per field
00.5×1.5×
Mart Speek · 1×
Citations per year

Countries citing papers authored by Melissa Vetter

Since Specialization
Citations

This map shows the geographic impact of Melissa Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Vetter more than expected).

Fields of papers citing papers by Melissa Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Vetter. The network helps show where Melissa Vetter may publish in the future.

Co-authorship network of co-authors of Melissa Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Vetter. A scholar is included among the top collaborators of Melissa Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Vetter. Melissa Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2 3
3 285
4 6
5 2
6 217
7 77
8 7

About Melissa Vetter

Melissa Vetter is a scholar working on Cancer Research, Immunology and Allergy and Management Science and Operations Research, having authored 8 papers that have together received 597 indexed citations. Recurring topics across this work include Chromosomal and Genetic Variations (3 papers), RNA and protein synthesis mechanisms (3 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Plant Science (429 citations), Molecular Biology (518 citations) and Genetics (109 citations). Melissa Vetter has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Haig H. Kazazian, Lili Zhang, John L. Goodier, Hiroki Kano, Eric Ostertag, George L. Gerton, Irene Godoy, Laurel A Bastone, Richard Cordaux and Mark A. Batzer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026